Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma

H Takita, A Brugarolas, A Mittelman

Cancer Chemotherapy Reports. Part 3

|March 1, 1973

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Determining personalized treatment by gene expression profiling in metastatic breast carcinoma patients: a pilot study.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2017

Preliminary Experience with Short Course High-Dose Mitoxantrone in Combination with High-Dose Cytarabine in Patients with Acute Leukemia and Blastic Phase of Chronic Myelogenous Leukemia.

Leukemia & lymphoma·2016

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule.

Leukemia & lymphoma·2016

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2011

Relationship between response rate and median survival in patients with advanced nonsmall cell lung-cancer - comparison of onconase(r) with other anticancer agents.

International journal of oncology·2011

Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparation PC SPES.

International journal of oncology·2011

See all related articles

Related Experiment Videos

Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma

Related Concept Videos

Related Articles